Forbes March 31, 2025
For companies seeking to upgrade their technology, the “build or buy” question—that is, whether to create purpose-built software in-house or buy software for said purpose from an outside vendor—is one that can cause confusion, ambivalence and tension even in the most sanguine C-suites. The debate rests on considerations of cost, efficiency, time-to-operation, flexibility, security and a host of other issues, each of which must be valued against the others in this paradigm. Moreover, the final decision is not always black and white, with some companies choosing composable, hybrid approaches. What to do?
Within our space, the companies facing this decision are typically large pharmaceutical organizations—household names like...
Today's Sponsors
Today's Sponsor